
Neladalkib received accelerated approval for adults with advanced ALK-positive NSCLC after specified prior therapies, supported by durable responses in the ALKOVE-1 trial.
Oxcarbazepine Oral Suspension, USP 300 mg/5 mL is available in 250 mL bottles.
Camber Pharmaceuticals is pleased to announce the addition of Oxcarbazepine Oral Suspension, USP to its current portfolio.
Oxcarbazepine Oral Suspension, USP is indicated for:
Oxcarbazepine Oral Suspension, USP 300 mg/5 mL is available in 250 mL bottles.
To find out more about Oxcarbazepine Oral Suspension, USP, please visit






